[go: up one dir, main page]

CA2049655A1 - Composition pharmaceutique pour inhiber l'aggregation des plaquettes - Google Patents

Composition pharmaceutique pour inhiber l'aggregation des plaquettes

Info

Publication number
CA2049655A1
CA2049655A1 CA2049655A CA2049655A CA2049655A1 CA 2049655 A1 CA2049655 A1 CA 2049655A1 CA 2049655 A CA2049655 A CA 2049655A CA 2049655 A CA2049655 A CA 2049655A CA 2049655 A1 CA2049655 A1 CA 2049655A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
platelet aggregation
alkyl group
lower alkyl
inhibiting platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2049655A
Other languages
English (en)
Other versions
CA2049655C (fr
Inventor
Akio Odawara
Yasuhiko Sasaki
Sakae Murata
Hiroshi Narita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2243729A external-priority patent/JPH078799B2/ja
Priority claimed from JP2243728A external-priority patent/JPH078798B2/ja
Application filed by Individual filed Critical Individual
Publication of CA2049655A1 publication Critical patent/CA2049655A1/fr
Application granted granted Critical
Publication of CA2049655C publication Critical patent/CA2049655C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002049655A 1990-09-17 1991-08-21 Composition pharmaceutique pour inhiber l'aggregation des plaquettes Expired - Fee Related CA2049655C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2243729A JPH078799B2 (ja) 1990-09-17 1990-09-17 血小板凝集抑制組成物
JP2243728A JPH078798B2 (ja) 1990-09-17 1990-09-17 血小板凝集抑制組成物
JP243728/1990 1990-09-17
JP243729/1990 1990-09-17

Publications (2)

Publication Number Publication Date
CA2049655A1 true CA2049655A1 (fr) 1992-03-18
CA2049655C CA2049655C (fr) 1996-11-12

Family

ID=26536403

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002049655A Expired - Fee Related CA2049655C (fr) 1990-09-17 1991-08-21 Composition pharmaceutique pour inhiber l'aggregation des plaquettes

Country Status (9)

Country Link
US (1) US5387581A (fr)
EP (1) EP0476854B1 (fr)
KR (1) KR0145689B1 (fr)
AT (1) ATE106734T1 (fr)
CA (1) CA2049655C (fr)
DE (1) DE69102379T2 (fr)
DK (1) DK0476854T3 (fr)
ES (1) ES2057777T3 (fr)
FR (1) FR2666741B1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637582A (en) * 1992-10-23 1997-06-10 Tanabe Seiyaku Co., Ltd. Peripheral circulation improving agent
ATE157874T1 (de) * 1992-10-23 1997-09-15 Tanabe Seiyaku Co Mittel zur verbesserung der peripheren durchblutung
MA24512A1 (fr) * 1996-01-17 1998-12-31 Univ Vermont And State Agrienl Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
US20070190059A1 (en) * 1996-01-17 2007-08-16 Smithkline Beecham Corporation Antithrombotic agents
US20030235587A1 (en) * 1998-08-07 2003-12-25 Feuerstein Giora Z. Anticoagulant agents useful in treatment of thrombosis
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
ATE345816T1 (de) * 2000-05-15 2006-12-15 Smithkline Beecham Corp Antithrombose agenzien
JP2007538257A (ja) 2004-05-17 2007-12-27 メドトロニック・インコーポレーテッド ポイント・オブ・ヘパリン測定システム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative
FR2589358B1 (fr) * 1985-07-30 1987-12-04 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'aspirine
DE3626097A1 (de) * 1986-07-31 1988-02-11 Goedecke Ag Wirkstoffkombination enthaltend diltiazem und acetylsalicylsaeure

Also Published As

Publication number Publication date
KR0145689B1 (ko) 1998-08-17
KR920005986A (ko) 1992-04-27
DK0476854T3 (da) 1994-07-11
CA2049655C (fr) 1996-11-12
EP0476854B1 (fr) 1994-06-08
FR2666741B1 (fr) 1993-01-08
ES2057777T3 (es) 1994-10-16
US5387581A (en) 1995-02-07
DE69102379D1 (de) 1994-07-14
ATE106734T1 (de) 1994-06-15
FR2666741A1 (fr) 1992-03-20
EP0476854A1 (fr) 1992-03-25
DE69102379T2 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
CA2225761A1 (fr) Derives de la prostaglandine et leurs utilisations
CA2001203A1 (fr) Dithiocarbamoyl quinolones antimicrobiens
EP0283970A3 (fr) Composés peptidiques, leur procédé de préparation et les compositions pharmaceutiques les contenant
CA2172354A1 (fr) Derives des acides benzazepine-, benzoxazepine- et benzothiazepine-n-acetiques; methode de preparation et compositions pharmaceutiques a base de ces derives
CA2035314A1 (fr) Antifongiques a base de triazole
CA1251209A (fr) Derives de dishydropyridazinone
CA2297011A1 (fr) Agent therapeutique ou prophylactique de traitement de la glomerulopathie
CA2037408A1 (fr) Solution macrolide pharmaceutique non-aqueuse
CA2250243A1 (fr) Derives d'acide de thiazoline
CA2128205A1 (fr) Derives du methotrexate
CA2050255A1 (fr) Derives du 1-methylcarbapenem et procede d'obtention
CA2038848A1 (fr) Derives de l'hydantoine
KR960007592A (ko) 신규한 피롤로카바졸
CA2026890A1 (fr) Derives de guinoline, leur production et leur emploi
CA2049655A1 (fr) Composition pharmaceutique pour inhiber l'aggregation des plaquettes
CA2013518A1 (fr) Derives de thieno-triazolo-diazepine, procede de preparation et composes therapeutiques les contenant
CA2126518A1 (fr) Utilisation de phenylalkylamines
CA2241092A1 (fr) Derives de 1-methylcarbapenem
EP0268990A3 (fr) Dérivés de benzothiadiazine, leurs procédés de préparation et compositions pharmaceutiques les contenant
EP0357089A3 (fr) Composé céphem comme agent antimicrobien et sa préparation
CA2032254A1 (fr) Derives de glycerol, mode de preparation et compositions therapeutiques en contenant
EP0819672A3 (fr) Dérivés d'acide hydroxamique et leur utilisation pour l'amélioration de la stabilité de l'image latente d'un matériau photographique à l'halogénure d'argent.
CA2228078A1 (fr) Composition a administrer par voie orale contenant des composes de pyridazinone
CA2187541A1 (fr) Derives de benzodiazepines, sels issus de ces derives, et medicaments a base de ces derives et sels
CA2089207A1 (fr) Compose tricyclique amphotere

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed